135 related articles for article (PubMed ID: 37774229)
1. Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Single Turkey Center Study.
Bilican G; Özgül S; Ekmen N; Moral K; Küçük H; Dumanlı S; Abiyev A; Karakan T; Kekilli M
J Gastrointestin Liver Dis; 2023 Sep; 32(3):367-370. PubMed ID: 37774229
[TBL] [Abstract][Full Text] [Related]
2. The impact of COVID-19 on the diagnosis and treatment of HCC: analysis of a nationwide registry for advanced liver diseases (REAL).
Okushin K; Tateishi R; Hirakawa S; Tachimori H; Uchino K; Nakagomi R; Yamada T; Nakatsuka T; Minami T; Sato M; Fujishiro M; Hasegawa K; Eguchi Y; Kanto T; Yoshiji H; Izumi N; Kudo M; Koike K
Sci Rep; 2024 Feb; 14(1):2826. PubMed ID: 38310156
[TBL] [Abstract][Full Text] [Related]
3. Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Tertiary Care Center in North-West Italy.
Ribaldone DG; Caviglia GP; Gaia S; Rolle E; Risso A; Campion D; Brunocilla PR; Saracco GM; Carucci P
Curr Oncol; 2022 Feb; 29(3):1422-1429. PubMed ID: 35323319
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.
Fenoglio L; Serraino C; Castagna E; Cardellicchio A; Pomero F; Grosso M; Senore C
World J Gastroenterol; 2013 Jun; 19(21):3207-16. PubMed ID: 23745022
[TBL] [Abstract][Full Text] [Related]
5. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
6. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital.
Pomej K; Scheiner B; Hartl L; Balcar L; Meischl T; Mandorfer M; Reiberger T; Müller C; Trauner M; Pinter M
PLoS One; 2021; 16(8):e0256544. PubMed ID: 34437610
[TBL] [Abstract][Full Text] [Related]
8. The COVID-19 Pandemic Highlights Opportunities to Improve Hepatocellular Carcinoma Screening and Diagnosis in a National Health System.
Kim NJ; Rozenberg-Ben-Dror K; Jacob DA; Berry K; Ioannou GN
Am J Gastroenterol; 2022 Apr; 117(4):678-684. PubMed ID: 35029156
[TBL] [Abstract][Full Text] [Related]
9. The Impact of the COVID-19 Pandemic on Hepatocellular Carcinoma Time to Treatment Initiation: A National Cancer Database Study.
Rasic G; Beaulieu-Jones BR; Chung SH; Romatoski KS; Kenzik K; Ng SC; Tseng JF; Sachs TE
Ann Surg Oncol; 2023 Jul; 30(7):4249-4259. PubMed ID: 37099088
[TBL] [Abstract][Full Text] [Related]
10. Telephone-Only Visits Preserved Hepatocellular Cancer Screening Rates in Patients with Cirrhosis Early in the COVID-19 Pandemic.
Rudnick SR; Ugwuegbu J; Soufleris SJ; Bundy R; Dharod A; Russo MW
Dig Dis Sci; 2023 May; 68(5):1791-1796. PubMed ID: 36562886
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and Therapeutic Delays in Patients With Hepatocellular Carcinoma.
Rao A; Rich NE; Marrero JA; Yopp AC; Singal AG
J Natl Compr Canc Netw; 2021 May; 19(9):1063-1071. PubMed ID: 34077908
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study.
Akarca US; Unsal B; Sezgin O; Yalcin K; Akdogan M; Gonen C; Gunduz F; Ozenirler S; Sonsuz A; Dincer D; Tekin SB; Yucel I; Akbulut H; Alkım C; Ozyilkan O; Baygul A; Cevik ZM; Idilman R; Study Group OBOKR
Turk J Gastroenterol; 2021 Dec; 32(12):1019-1028. PubMed ID: 34876392
[TBL] [Abstract][Full Text] [Related]
13. Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high-volume liver surgery center in East Asia.
Liu YW; Yong CC; Lin CC; Wang CC; Chen CL; Cheng YF; Wang JH; Yen YH; Chen CH
J Surg Oncol; 2020 Dec; 122(8):1587-1594. PubMed ID: 32815189
[TBL] [Abstract][Full Text] [Related]
14. Determinants of survival following hepatocellular carcinoma in Egyptian patients with untreated chronic HCV infection in the pre-DAA era.
Waziry R; Gomaa A; Waked I; Dore GJ
Arab J Gastroenterol; 2018 Mar; 19(1):26-32. PubMed ID: 29506913
[TBL] [Abstract][Full Text] [Related]
15. Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic.
Mehta N; Parikh ND; Kelley RK; Hameed B; Singal AG
Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1520-1530. PubMed ID: 32652308
[TBL] [Abstract][Full Text] [Related]
16. Impact of the COVID-19 pandemic on patients with hepatocellular carcinoma in the West of Scotland: a cohort study.
McLaren AS; Spoor JA; Cartwright D; Naylor G; Barclay S; Priest M; Puttagunta S; Armstrong K; Ballantyne S; Stanley A; Jeffry Evans TR;
BMJ Open Gastroenterol; 2023 Nov; 10(1):. PubMed ID: 37989352
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
[TBL] [Abstract][Full Text] [Related]
18. BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group.
Farinati F; Vanin V; Giacomin A; Pozzan C; Cillo U; Vitale A; Di Nolfo AM; Del Poggio P; Benvegnu' L; Rapaccini G; Zoli M; Borzio F; Giannini EG; Caturelli E; Trevisani F;
Liver Int; 2015 Jan; 35(1):223-31. PubMed ID: 25074434
[TBL] [Abstract][Full Text] [Related]
19. Chinese expert recommendations on management of hepatocellular carcinoma during COVID-19 pandemic: a nationwide multicenter survey.
Zhao H; Zhou A; Zhou J; Bi X; Yan S; Jin J; Wei W; Li M; Gong C; Chen Q; Luo Z; Li N; Mao R; Chen X; Chen B; Zheng R; Zhao J; Han Y; Li Z; Che X; Tang Y; Sun Y; Huang Z; Zhang Y; Wang X; Zhang Y; Lu Z; Dang X; Song T; Liu C; Yue P; Yan D; Yue A; Zhang R; Luo S; Tan J; Zhang X; Bai X; Zhang X; He M; Xie Y; Wang W; Yang P; Yang Y; Zhang Y; Li Q; Peng T; Wang Z; Chen Y; Shang C; Liang Y; Zhang B; Zhang F; Wang L; Li D; Liu B; Zhu X; Hu Q; Chen M; Xiu D; Xia F; Zhang Y; Zeng Y; Mao Y; Li X; Ba Y; Liang T; Shen F; Liu L; Cai X; Zhou J; Cai J
HPB (Oxford); 2022 Mar; 24(3):342-352. PubMed ID: 34400051
[TBL] [Abstract][Full Text] [Related]
20. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area.
Amaddeo G; Brustia R; Allaire M; Lequoy M; Hollande C; Regnault H; Blaise L; Ganne-Carrié N; Séror O; Larrey E; Lim C; Scatton O; El Mouhadi S; Ozenne V; Paye F; Balladur P; Dohan A; Massault PP; Pol S; Dioguardi Burgio M; Vilgrain V; Sepulveda A; Cauchy F; Luciani A; Sommacale D; Leroy V; Roudot-Thoraval F; Bouattour M; Nault JC;
JHEP Rep; 2021 Feb; 3(1):100199. PubMed ID: 33163949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
